Air Polishing for Pain and Compliance in Supportive Periodontal Therapy
Efficacy of Air Polishing on Pain Perception and Compliance With Supportive Periodontal Therapy: A Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Supportive periodontal therapy (SPT) is essential for maintaining periodontal stability and preventing disease recurrence in patients who have been successfully treated for periodontitis. However, long-term effectiveness depends on regular attendance at maintenance visits, and negative experiences associated with periodontal instrumentation, such as pain or discomfort, may affect patient acceptance and adherence to the maintenance program. The aim of this randomized clinical trial is to evaluate whether supportive periodontal therapy performed using an air-polishing device with low-abrasive trehalose powder reduces patient-perceived pain and improves the clinical experience compared with conventional biofilm removal using ultrasonic instrumentation. The study will also assess whether the use of air polishing is associated with better adherence to the periodontal maintenance program while maintaining comparable periodontal clinical outcomes. Forty periodontally stabilized adult patients enrolled in the supportive periodontal therapy program of the Master's Degree in Periodontology and Peri-implantology at the University of Barcelona will be randomly allocated in a 1:1 ratio to one of two parallel treatment groups. The control group will receive conventional supportive periodontal therapy using ultrasonic instrumentation, while the experimental group will receive supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder. Participants will be followed for 24 months. The primary outcome will be patient-perceived pain associated with supportive periodontal therapy, assessed using a visual analogue scale (VAS). Secondary outcomes will include treatment duration, adherence to scheduled maintenance visits, patient experience and acceptance of treatment, and periodontal clinical parameters. Periodontal status will be monitored throughout follow-up by assessing probing pocket depth, clinical attachment level, bleeding on probing, and plaque index. This study aims to determine whether air polishing with trehalose powder can provide a more comfortable and patient-centered approach to supportive periodontal therapy without compromising periodontal clinical outcomes, and whether an improved treatment experience may contribute to better long-term adherence to periodontal maintenance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2026
CompletedFirst Posted
Study publicly available on registry
September 24, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
ExpectedSeptember 24, 2026
September 1, 2026
Same day
September 12, 2026
September 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain perceived during supportive periodontal therapy
Pain perceived by the participant during the supportive periodontal therapy session will be assessed using a Visual Analogue Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). The outcome will be compared between participants treated with trehalose air-polishing and those treated with ultrasonic instrumentation.
Immediately after the supportive periodontal therapy session
Secondary Outcomes (10)
Patient-reported treatment experience
Immediately after each supportive periodontal therapy session
Duration of supportive periodontal therapy session
At each supportive periodontal therapy visit throughout the 24-month follow-up
Adherence to supportive periodontal therapy
Throughout the 24-month follow-up
Probing pocket depth (PPD)
Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up
Clinical attachment level (CAL)
Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.
- +5 more secondary outcomes
Study Arms (2)
Trehalose Air-Polishing Group
EXPERIMENTALParticipants allocated to this group will receive supportive periodontal therapy (SPT) using an air-polishing device with low-abrasive trehalose powder for subgingival biofilm removal.
Ultrasonic Instrumentation Group
ACTIVE COMPARATORParticipants allocated to this group will receive supportive periodontal therapy (SPT) using conventional ultrasonic instrumentation for subgingival biofilm and calculus removal.
Interventions
Subgingival biofilm removal during supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder.
Conventional subgingival debridement during supportive periodontal therapy using ultrasonic instrumentation.
Eligibility Criteria
You may qualify if:
- Men or women aged 18 years or older who voluntarily agree to sign the informed consent form before any study-related procedure is performed.
- ASA physical status I or II.
- Initial diagnosis of Stage I-III periodontitis according to the 2017 World Workshop, periodontally treated and stabilized, and enrolled in a supportive periodontal therapy (SPT) program.
- Non-smokers or light smokers (\<10 cigarettes/day).
- Commitment to attend all follow-up visits over the 24-month study period.
You may not qualify if:
- Patients requiring local anesthesia or anxiolytic premedication to undergo supportive periodontal therapy (SPT).
- Patients with pacemakers, implantable cardioverter-defibrillators, or neurostimulators.
- Pregnant women.
- Patients with infectious respiratory diseases.
- Patients with systemic diseases or neurological disorders that may alter pain perception.
- Patients receiving medications that may influence pain perception (e.g., opioids or gabapentin).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Odontològic Universitat de Barcelona
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edgar Martínez García, DDS
University of Barcelona
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will be blinded to treatment allocation. Due to the nature of the interventions, the operator performing supportive periodontal therapy cannot be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 12, 2026
First Posted
September 24, 2026
Study Start
October 1, 2026
Primary Completion
October 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
September 24, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with external researchers, in accordance with the study protocol and applicable data protection regulations.